Trial Profile
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Nelfinavir (Primary)
- Indications Systemic lupus erythematosus
- Focus Pharmacodynamics
- Acronyms NISLE
- 21 Feb 2020 Status changed from completed to discontinued.
- 25 Jul 2018 Status changed from recruiting to completed.
- 20 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.